Claris Lifesciences gets nod to sell stake in JV to Otsuka

08 May 2017 Evaluate

Claris Lifesciences has received an approval for the sale and transfer of the equity shares of Otsuka Pharmaceutical India (formerly knowns as Claris Otsuka) to Otsuka Pharmaceutical Factory, Inc for a consideration of $20 million. The board of directors at their meeting held on May 8, 2017 has approved for the same.

Claris Lifesciences is a multi-business enterprise and the holding company of Claris Injectables, a wholly- owned subsidiary dealing in Speciality Injectables business and has a minority stake in Claris Otsuka. Claris has a total of 11 approved products in the US, around 25 ANDAs under review with the FDA and markets its products in 75+ countries.


Peers
Company Name CMP
Redington 205.70
Adani Enterprises 1832.30
Amrapali Industries 13.78
Rashi Peripheral 341.25
PDS 253.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×